Shanghai Rongtai Health Technology (SHSE:603579) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603579 Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
68 GF Score
Price ¥16.30
GF Value ¥15.92
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Shanghai Rongtai Health Technology LT-Debt-to-Total-Asset?

Shanghai Rongtai Health Technology SHSE:603579 -2.22% 68 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates SHSE:603579 with a GF Score™ of 68/100 and a GF Value™ of ¥15.92 (Fairly Valued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanghai Rongtai Health Technology's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Shanghai Rongtai Health Technology's long-term debt to total assets ratio declined from Mar. 2025 (0.20) to Mar. 2026 (0.00). It may suggest that Shanghai Rongtai Health Technology is progressively becoming less dependent on debt to grow their business.

Shanghai Rongtai Health Technology  (SHSE:603579) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanghai Rongtai Health Technology LT-Debt-to-Total-Asset Related Terms

Shanghai Rongtai Health Technology LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Shanghai Rongtai Health Technology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rongtai Health Technology LT-Debt-to-Total-Asset Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.18 0.19 0.17 0.00

Shanghai Rongtai Health Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.19 0.00 0.00 0.00
SHSE:603579
68GF Score
Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Rongtai Health Technology LT-Debt-to-Total-Asset Calculation

Shanghai Rongtai Health Technology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=0/3574.13
=0.00

Shanghai Rongtai Health Technology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=0/3789.213
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Shanghai Rongtai Health Technology (SHSE:603579) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shanghai Rongtai Health Technology and its competitors.
Is Shanghai Rongtai Health Technology's LT-Debt-to-Total-Asset too high?
Shanghai Rongtai Health Technology's current LT-Debt-to-Total-Asset is 0.00. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's LT-Debt-to-Total-Asset compare to AS and HAS?
Shanghai Rongtai Health Technology's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Travel & Leisure company?
A good LT-Debt-to-Total-Asset depends on the Travel & Leisure industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shanghai Rongtai Health Technology and its competitors. Shanghai Rongtai Health Technology's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.92, compared to a current price of ¥16.30 — trading 2.4% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued. The current stock price of ¥16.30 is trading 2.4% above its estimated GF Value™ of ¥15.92. GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.

Key valuation signals for SHSE:603579:

  • LT-Debt-to-Total-Asset: 0.00
  • GF Value™: ¥15.92 vs. price of ¥16.30 (2.4% above fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Rongtai Health Technology Business Description

Address No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score

Get the complete analysis for SHSE:603579

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.30
Price
¥15.92
GF Value